PT94869A - Processo de preparacao de uma composicao terapeutica a base de moleculas de anticorpos anti-cd14 - Google Patents

Processo de preparacao de uma composicao terapeutica a base de moleculas de anticorpos anti-cd14

Info

Publication number
PT94869A
PT94869A PT94869A PT9486990A PT94869A PT 94869 A PT94869 A PT 94869A PT 94869 A PT94869 A PT 94869A PT 9486990 A PT9486990 A PT 9486990A PT 94869 A PT94869 A PT 94869A
Authority
PT
Portugal
Prior art keywords
antibody molecules
therapeutic composition
preparation process
composition based
sepsis
Prior art date
Application number
PT94869A
Other languages
English (en)
Other versions
PT94869B (pt
Inventor
Peter Tobias
Samuel D Wright
Richard Ulevitch
John C Mathison
Original Assignee
Scripps Clinic Res
Univ Rockefeller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic Res, Univ Rockefeller filed Critical Scripps Clinic Res
Publication of PT94869A publication Critical patent/PT94869A/pt
Publication of PT94869B publication Critical patent/PT94869B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Two-Way Televisions, Distribution Of Moving Picture Or The Like (AREA)
PT94869A 1989-08-01 1990-07-31 Processo de preparacao de uma composicao terapeutica a base de moleculas de anticorpos anti-cd14 PT94869B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38781789A 1989-08-01 1989-08-01

Publications (2)

Publication Number Publication Date
PT94869A true PT94869A (pt) 1991-04-18
PT94869B PT94869B (pt) 1997-04-30

Family

ID=23531466

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94869A PT94869B (pt) 1989-08-01 1990-07-31 Processo de preparacao de uma composicao terapeutica a base de moleculas de anticorpos anti-cd14

Country Status (14)

Country Link
US (4) US5730980A (pt)
EP (1) EP0485430B1 (pt)
JP (1) JP2744130B2 (pt)
AT (1) ATE171042T1 (pt)
AU (1) AU645515B2 (pt)
CA (1) CA2022429C (pt)
DE (1) DE69032662T2 (pt)
DK (1) DK0485430T3 (pt)
ES (1) ES2120948T3 (pt)
FI (1) FI920450A0 (pt)
GR (1) GR1003164B (pt)
IE (1) IE902770A1 (pt)
PT (1) PT94869B (pt)
WO (1) WO1991001639A1 (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69032662T2 (de) * 1989-08-01 1999-03-11 Scripps Research Inst Verfahren und zusammensetzungen zur verbesserung der symptome von sepsis
DE4029227A1 (de) * 1990-09-14 1992-03-19 Imtox Gmbh Arzneimittel enthaltend cd14
CA2133758A1 (en) * 1992-04-06 1993-10-14 Sanna M. Goyert A novel therapy for treating sepsis using a soluble form of recombinant cd14 myelomonocytic antigen
JPH08510909A (ja) * 1993-05-28 1996-11-19 ザ スクリップス リサーチ インスティチュート Ｃｄ１４媒介細胞活性化を抑制するための方法および組成物
US5731415A (en) 1993-06-17 1998-03-24 Xoma Corporation Lipopolysaccharide binding protein derivatives
US5891618A (en) 1994-01-24 1999-04-06 Xoma Corporation Method for quantifying LBP in body fluids
US5484705A (en) 1994-01-24 1996-01-16 Xoma Corporation Method for quantifying lipopolysaccharide binding protein
EP0792162B1 (en) 1994-09-16 2005-11-09 The Scripps Research Institute Use of antibodies to block the effects of gram-positive bacteria and mycobacteria
EP0793677A1 (en) * 1994-12-30 1997-09-10 Amgen Inc. Anti-inflammatory cd14 polypeptides
US5766593A (en) * 1994-12-30 1998-06-16 Amgen Inc. Anti-inflammatory CD14 peptides
AU5688596A (en) * 1995-04-13 1996-10-30 Deutsche Om Arzneimittel Gmbh Anti-cd14 antibodies for use in the induction of il-10 secre tion
AU6392996A (en) * 1995-06-19 1997-01-15 Sanna M. Goyert A method for inhibiting bacteremia and bacterial dissemination
WO1997042966A1 (en) * 1996-05-10 1997-11-20 Xoma Corporation Therapeutic uses of bpi protein products for human meningococcemia
NZ332954A (en) * 1996-05-23 2000-07-28 Xoma Corp Use of BPI protein products to treat humans with hemorrhage due to trauma
US6093693A (en) * 1996-11-18 2000-07-25 The Wellesley Hospital Foundation B cell activation
US6171586B1 (en) 1997-06-13 2001-01-09 Genentech, Inc. Antibody formulation
US6991790B1 (en) 1997-06-13 2006-01-31 Genentech, Inc. Antibody formulation
US5990082A (en) 1997-10-22 1999-11-23 Xoma Corporation Uses of lipopolysaccharide binding protein
CN1298299A (zh) 1998-02-07 2001-06-06 英国生物技术药物有限公司 抗菌剂
WO1999061468A2 (en) * 1998-05-27 1999-12-02 Gemma Biotechnology Ltd. The induction of antibiotic peptides by lait (scd14) protein
US6974698B1 (en) * 1999-01-15 2005-12-13 The United States Of America As Represented By The Department Of Health And Human Services Methods for delivering biologically active molecules into cells
WO2001022085A1 (fr) * 1999-09-17 2001-03-29 Mochida Pharmaceutical Co., Ltd. Procede de mesure fractionnel de proteine de cd14 soluble
US7264967B2 (en) * 2000-11-22 2007-09-04 Mochida Pharmaceutical Co., Ltd. Anti-CD14 monoclonal antibody having effect of inhibiting CD14/TLR binding
EP1348443A4 (en) * 2000-12-08 2005-07-06 Takeda Pharmaceutical COMBINED MEDICINES
WO2003105898A1 (en) * 2002-06-14 2003-12-24 Centocor, Inc. Modified "s" antibodies
US8329169B2 (en) 2003-05-15 2012-12-11 Genentech, Inc. Methods and compositions for the prevention and treatment of sepsis
US20060206947A1 (en) * 2005-02-28 2006-09-14 Scallon Bernard J Heterodimeric protein binding compositions
US7696211B2 (en) * 2005-04-29 2010-04-13 Wilson Constance N Methods and pharmaceutical compositions for treating sepsis
CN101189334B (zh) 2005-06-03 2013-11-06 持田制药株式会社 抗cd14抗体融合蛋白质
US20170107294A1 (en) * 2014-03-21 2017-04-20 Nordlandssykehuset Hf Anti-cd14 antibodies and uses thereof
WO2018191786A1 (en) * 2017-04-21 2018-10-25 Implicit Bioscience Pty Ltd Cd 14 antagonist antibodies for treating neurodegenerative diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5057598A (en) * 1983-05-06 1991-10-15 Centocor, Inc. Monoclonal antibodies reactive with endotoxin core
US4918163A (en) * 1985-09-27 1990-04-17 Pfizer Inc. Monoclonal antibodies specific for lipid-A determinants of gram negative bacteria
US4834976A (en) * 1986-07-03 1989-05-30 Genetic Systems Corporation Monoclonal antibodies to pseudomonas aeruginosa flagella
DE69032662T2 (de) * 1989-08-01 1999-03-11 Scripps Research Inst Verfahren und zusammensetzungen zur verbesserung der symptome von sepsis

Also Published As

Publication number Publication date
US5730980A (en) 1998-03-24
FI920450A0 (fi) 1992-01-31
DE69032662T2 (de) 1999-03-11
CA2022429A1 (en) 1991-02-02
CA2022429C (en) 1998-12-01
EP0485430A1 (en) 1992-05-20
JPH05501399A (ja) 1993-03-18
PT94869B (pt) 1997-04-30
AU645515B2 (en) 1994-01-20
DK0485430T3 (da) 1999-06-14
JP2744130B2 (ja) 1998-04-28
IE902770A1 (en) 1991-02-27
GR900100582A (el) 1991-12-30
US6495332B2 (en) 2002-12-17
US6297049B1 (en) 2001-10-02
US20020034509A1 (en) 2002-03-21
GR1003164B (el) 1999-07-05
WO1991001639A1 (en) 1991-02-21
ES2120948T3 (es) 1998-11-16
US6045795A (en) 2000-04-04
AU6146190A (en) 1991-03-11
DE69032662D1 (de) 1998-10-22
EP0485430A4 (en) 1993-03-03
ATE171042T1 (de) 1998-10-15
EP0485430B1 (en) 1998-09-16

Similar Documents

Publication Publication Date Title
PT94869A (pt) Processo de preparacao de uma composicao terapeutica a base de moleculas de anticorpos anti-cd14
FI103506B1 (fi) Menetelmä syklisten aminohappojohdannaisten valmistamiseksi ja menetelmässä käytettävä välituote
FI932561A (fi) Proteiner med foeraendrade epitoper och foerfaranden foer deras framstaellning
FI893571A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten, substituoitujen aminometyylibentsodihydropyraanien ja aminometyyli(di- ja tetra)hydronaftaleenien valmistamiseksi
BR9709068A (pt) Processo de tratamento.
ATE61523T1 (de) Mittel zur verabreichung von hyaluronsaeure an saeuger.
NO932610D0 (no) Metode for aa forebygge eller behandle tnf-induserte sykdommer
EA199700413A1 (ru) Композиция, содержащая вакцину и конъюгат антигена и полисахарида, адсорбированные на фосфате алюминия
DK513385D0 (da) Polypeptid, fremgangsmaade til dets fremstilling og farmaceutisk praeparat indeholdende et saadant polypeptid
DK0502925T3 (da) præparat til behandling af inflammatoriske tarmlidelser
ID945B (id) Turunan-turunan baru kroman dan tiokroman
DE69034226D1 (de) Herstellungsverfahren von Huperzine A und deren Analogen und Verbindungen nützlich dazu
ATE308994T1 (de) Gebrauch von antikörpern zur verhinderung von auswirkungen hervorgerufen durch grampositive- und myko-bakterien
DE69213935T2 (de) Neue heterocyclische carbonsäuren
ES2139674T3 (es) Metodo para tratar la sintomatologia del sindrome premenstrual con vitamina d o vitamina d y calcio.
HUT59600A (en) Process for producing pharmaceutical compositions containing 5-methyl-isoxazoe-4-carboxylik-anilides or alpha-/2-hydroxy-ethylidene/-alpha-cyano-acetic-anilides for treating eye-diseases
DK0643585T3 (da) Anvendelsen af lipoprotein-associeret koagulationsinhibitor (LACI) til fremstilling af et lægemiddel til behandlingen af ak
DE69533311D1 (de) Verfahren zur behandlung von autoimmunerkrankungen mittels typ-1-interferonen
PT95456A (pt) Processo para a preparacao de preparados de combinacao de acido acetilsalicilico e de derivados de carbaciclina com accao antitrombotica
BR0111852A (pt) Nova interferona para o tratamento de esclerose múltipla
ES2062175T3 (es) Medicamentos y productos dieteticos con contenido de nuevos derivados de acilaminoacidos.
FR2672888B1 (fr) Nouvelles urees et thiourees, leur preparation et leur application en therapeutique.
ES2125892T3 (es) Produccion y utilizacion de butirilcolinesterasa.
ES2015349A6 (es) Metodo para producir anticuerpos inmunologicamente reactivos con angiogenina.
FR2303558A1 (fr) Preparation therapeutique pour traiter l'infection sous forme de pneumonie hemorragique du vison et de mastite bovine causees par la pseudomonas aeruginosa

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19901025

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20120130